Regulation of CD20 expression by radiation-induced changes in intracellular redox status

Free Radical Biology and Medicine

Volumn 44, Issue 4, 2008, Pages 614-623

  Gupta, Damodar ^a,b   Crosby, Meredith E ^b,c   Almasan, Alexandru ^a,b   Macklis, Roger M ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Antioxidants; CD20; Free radicals; Ionizing radiation; Mitochondria; Mitochondrial membrane potential; Reactive oxygen species

Indexed keywords

AMIFOSTINE; ANTIOXIDANT; ASCORBIC ACID; BUTHIONINE SULFOXIMINE; CATALASE; CD20 ANTIGEN; GLUTATHIONE; HYDROGEN PEROXIDE; MACROGOL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL TYPE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; KINETICS; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; REGULATORY MECHANISM; TIME; X IRRADIATION;

ANTIGENS, CD20; ANTIOXIDANTS; CELL SURVIVAL; HUMANS; HYDROGEN PEROXIDE; MEMBRANE POTENTIAL, MITOCHONDRIAL; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TUMOR CELLS, CULTURED; X-RAYS;

EID: 38649106133     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.10.048     Document Type: Article

References (39)

1. Tedder T.F., Disteche C.M., Louie E., Adler D.A., Croce C.M., Schlossman S.F., and Saito H. The gene that encodes the human CD20 (B1) differentiation antigen is located on chromosome 11 near the t(11;14) (q13;q32) translocation site. J. Immunol. 142 (1989) 2555-2559
2. Tedder T.F., and Engel P. CD20: a regulator of cell-cycle progression of B lymphocytes. Immunol. Today 15 (1994) 450-454
3. Pohlman B., Sweetenham J., and Macklis R.M. Review of clinical radioimmunotherapy. Expert Rev. Anticancer Ther. 6 (2006) 445-461
4. Manshouri T., Do K.A., Wang X., Giles F.J., O'Brien S.M., Saffer H., Thomas D., Jilani I., Kantarjian H.M., Keating M.J., and Albitar M. Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significance. Blood 101 (2003) 2507-2513
5. Lundin J., and Osterborg A. Advances in the use of monoclonal antibodies in the therapy of chronic lymphocytic leukemia. Semin. Hematol. 41 (2004) 234-245
6. Golay J., Lazzari M., Facchinetti V., Bernasconi S., Borleri G., Barbui T., Rambaldi A., and Introna M. CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59. Blood 98 (2001) 3383-3389
7. Huhn D., von Schilling C., Wilhelm M., Ho A.D., Hallek M., Kuse R., Knauf W., Riedel U., Hinke A., Srock S., Serke S., Peschel C., and Emmerich B. Rituximab therapy of patients with B-cell chronic lymphocytic leukemia. Blood 98 (2001) 1326-1331
8. Dancescu M., Wu C., Rubio M., Delespesse G., and Sarfati M. IL-4 induces conformational change of CD20 antigen via a protein kinase C-independent pathway: antagonistic effect of anti-CD40 monoclonal antibody. J. Immunol. 148 (1992) 2411-2416
9. Sivaraman S., Venugopal P., Ranganathan R., Deshpande C.G., Huang X., Jajeh A., Gregory S.A., O'Brien T., and Preisler H.D. Effect of interferon-alpha on CD20 antigen expression of B-cell chronic lymphocytic leukemia. Cytokines Cell. Mol. Ther. 6 (2000) 81-87
10. Sivaraman S., Deshpande C.G., Ranganathan R., Huang X., Jajeh A., O'Brien T., Huang R.W., Gregory S.A., Venugopal P., and Preisler H.D. Tumor necrosis factor modulates CD 20 expression on cells from chronic lymphocytic leukemia: a new role for TNF alpha?. Microsc. Res. Tech. 50 (2000) 251-257
11. Venugopal P., Sivaraman S., Huang X.K., Nayini J., Gregory S.A., and Preisler H.D. Effects of cytokines on CD20 antigen expression on tumor cells from patients with chronic lymphocytic leukemia. Leuk. Res. 24 (2000) 411-415
12. Chow K.U., Schneider B., Mitrou P.S., and Weidmann E. Influence of various cytokines on the expression of CD20 on the surface of CLL-cells in vitro. Leuk. Res. 25 (2001) 99-100
13. Wojciechowski W., Li H., Marshall S., Dell'Agnola C., and Espinoza-Delgado I. Enhanced expression of CD20 in human tumor B cells is controlled through ERK-dependent mechanisms. J. Immunol. 174 (2005) 7859-7868
14. Turpaev K.T. Reactive oxygen species and regulation of gene expression. Biochemistry (Moscow) 67 (2002) 281-292
15. Buchanan B.B., and Balmer Y. Redox regulation: a broadening horizon. Annu. Rev. Plant Biol. 56 (2005) 187-220
16. Kunala S., and Macklis R.M. Ionizing radiation induces CD20 surface expression on human B cells. Int. J. Cancer 96 (2001) 178-181
17. Mazumder S., Gong B., and Almasan A. Cyclin E induction by genotoxic stress leads to apoptosis of hematopoietic cells. Oncogene 19 (2000) 2828-2835
18. Chan H.T., Hughes D., French R.R., Tutt A.L., Walshe C.A., Teeling J.L., Glennie M.J., and Cragg M.S. CD20-induced lymphoma cell death is independent of both caspases and its redistribution into Triton X-100 insoluble membrane rafts. Cancer Res. 63 (2003) 5480-5489
19. Crosby M.E., Jacobberger J., Gupta D., Macklis R.M., and Almasan A. E2F4 regulates a stable G2 arrest response to genotoxic stress in prostate carcinoma. Oncogene 26 (2007) 1897-1909
20. Wang H.G., Rapp U.R., and Reed J.C. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87 (1996) 629-638
21. Treon S.P., Pilarski L.M., Belch A.R., Kelliher A., Preffer F.I., Shima Y., Mitsiades C.S., Mitsiades N.S., Szczepek A.J., Ellman L., Harmon D., Grossbard M.L., and Anderson K.C. CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications. J. Immunother. 1997 25 (2002) 72-81
22. +-ATPase to hypertrophy and its marker genes in cardiac myocytes. J. Biol. Chem. 274 (1999) 19323-19328
23. Grant E.R., Dubin A.E., Zhang S.P., Zivin R.A., and Zhong Z. Simultaneous intracellular calcium and sodium flux imaging in human vanilloid receptor 1 (VR1)-transfected human embryonic kidney cells: a method to resolve ionic dependence of VR1-mediated cell death. J. Pharmacol. Exp. Ther. 300 (2002) 9-17
24. Chen Q., Chai Y.C., Mazumder S., Jiang C., Macklis R.M., Chisolm G.M., and Almasan A. The late increase in intracellular free radical oxygen species during apoptosis is associated with cytochrome c release, caspase activation, and mitochondrial dysfunction. Cell Death Differ. 10 (2003) 323-334
25. Mustonen R., Bouvier G., Wolber G., Stohr M., Peschke P., and Bartsch H. A comparison of gamma and neutron irradiation on Raji cells: effects on DNA damage, repair, cell cycle distribution and lethality. Mutat. Res. 429 (1999) 169-179
26. Chen Q., Gong B., and Almasan A. Distinct stages of cytochrome c release from mitochondria: evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis. Cell Death Differ. 7 (2000) 227-233
27. Drew R., and Miners J.O. The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation. Biochem. Pharmacol. 33 (1984) 2989-2994
28. Somosy Z. Radiation response of cell organelles. Micron 31 (2000) 165-181
29. Ohashi T., Mizutani A., Murakami A., Kojo S., Ishii T., and Taketani S. Rapid oxidation of dichlorodihydrofluorescin with heme and hemoproteins: formation of the fluorescein is independent of the generation of reactive oxygen species. FEBS Lett. 511 (2002) 21-27
30. Gogvadze V., Orrenius S., and Zhivotovsky B. Multiple pathways of cytochrome c release from mitochondria in apoptosis. Biochim. Biophys. Acta 1757 (2006) 639-647
31. Dalton T.P., Shertzer H.G., and Puga A. Regulation of gene expression by reactive oxygen. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 67-101
32. Grdina D.J., Murley J.S., Kataoka Y., Zhou D., and Seed T.M. Radioprotectors: current status and new directions. Radiat. Res. 163 (2005) 704-705
33. Grdina D.J., Murley J.S., and Kataoka Y. Radioprotectants: current status and new directions. Oncology 63 Suppl. 2 (2002) 2-10
34. Dest V.M. Radioprotectants: adding quality of life to survivorship?. Semin. Oncol. Nurs. 22 (2006) 249-256
35. Dennis M.F., Stratford M.R., Wardman P., and Watfa R.R. Increase in intracellular cysteine after exposure to dithiothreitol: implications in radiobiology. Int. J. Radiat. Biol. 56 (1989) 877-883
36. Dennis M.F., Stratford M.R.L., Wardman P., and White J. Thiols and antioxidants in radiobiology: chemical and bioanalytical problems. In: Seymour C.B., and Mothersill C. (Eds). New developments in fundamental and applied radiobiology (1991), Taylor & Francis, London 328-333
37. Cartron G., Watier H., Golay J., and Solal-Celigny P. From the bench to the bedside: ways to improve rituximab efficacy. Blood 104 (2004) 2635-2642
38. Safwat A. The role of low-dose total body irradiation in treatment of non-Hodgkin's lymphoma: a new look at an old method. Radiother. Oncol. 56 (2000) 1-8
39. Safwat A. The immunobiology of low-dose total-body irradiation: more questions than answers. Radiat. Res. 153 (2000) 599-604